Covid-19: Oxford-AstraZeneca vaccine approval 'moment of pride'

Name: Covid-19: Oxford-AstraZeneca vaccine approval 'moment of pride'
Uploaded: 2020-12-30T09:51:15.000Z
Duration: 2 min 34 s
Description: Prof Andrew Pollard, director of the Oxford Vaccine Group, says it is "a triumph for both academia and clinical research this year".

To play this video you need to enable JavaScript in your browser.

This video can not be played

The Oxford-AstraZeneca vaccine approval is "a real moment of pride" for the team behind it, says Prof Andrew Pollard, director of the Oxford Vaccine Group.

The UK has ordered 100 million doses vaccine, enough for 50 million people, with rollout beginning on 4 January.

Health

30 December 2020